COPD Clinical Trials 2024

What are the top hospitals conducting copd research?

Chronic obstructive pulmonary disease (COPD) is a debilitating respiratory condition that affects millions of people worldwide. Fortunately, there are several notable hospitals at the forefront of COPD research and clinical trials. In Newport Beach, California, a dedicated research site is currently conducting six active COPD trials while having completed nine trials in total since their first recorded trial in 2014. This location's commitment to finding innovative treatments for COPD showcases the significant progress being made in this field.

Meanwhile, in Tampa, Florida, another prominent research site has been making strides with five ongoing COPD trials and an impressive history of 14 completed studies dating back to their first trial in 2005. The dedication shown by these researchers highlights the urgency and importance placed on combating this chronic lung disease.

In McKinney, Texas, a valuable research site is actively involved in four current COPD trials and has achieved seven completed studies since initiating their inaugural trial in 2007. Their contributions bring hope to those living with COPD by exploring potential breakthroughs that can improve quality of life.

Winter Park's research site also plays an essential role with three active COPD trials underway along with ten previously conducted studies since recording their first trial in 2013. Their efforts contribute significantly to understanding and managing this complex respiratory condition.

Finally, located at North Dartmouth is yet another dedicated research site focusing on advancing our knowledge about COPD through three ongoing clinical trials as well as six accomplished investigations from their earliest recorded study also starting around the same time frame;in2013

These diverse locations demonstrate the widespread commitment to combating COPD across different regions within the United States. By participating in cutting-edge clinical trials at these top hospitals or supporting them through funding or advocacy efforts - we can collectively work towards improving treatment options for individuals living with this challenging disease

Which are the best cities for copd clinical trials?

Miami, Florida is a leading city for COPD clinical trials with 14 active studies. These trials involve investigating treatments like Itepekimab SAR440340, Astegolimab SC Q2W, and tiotropium bromide inhalation powder. Orlando, Florida also offers significant research opportunities with 9 ongoing trials focusing on treatments such as Itepekimab SAR440340, Mepolizumab, and Astegolimab. Gastonia, North carolina has 8 active trials exploring similar treatment options. Seattle, Washington and Newport Beach, California both have 7 active trials each that assess different interventions for COPD patients. These cities provide valuable resources for individuals seeking to participate in COPD clinical research to improve treatment outcomes.

Which are the top treatments for copd being explored in clinical trials?

Clinical trials investigating potential treatments for chronic obstructive pulmonary disease (COPD) have identified several promising candidates. Tozorakimab, a novel drug introduced in 2022, is currently being explored in three ongoing COPD trials and has shown promise in addressing this debilitating condition. Another hopeful contender is Itepekimab SAR440340, which entered the scene in 2020 and is now involved in two active COPD trials. Additionally, interventions specifically designed for COPD are also under investigation, with one trial currently underway to assess their effectiveness. These advancements offer renewed hope for individuals affected by COPD and highlight the continuous efforts of researchers striving to improve treatment options.

What are the most recent clinical trials for copd?

Exciting advancements in the field of COPD research are bringing hope to those living with this debilitating condition. Recent clinical trials have focused on exploring innovative treatment options, such as Tozorakimab—a promising candidate currently undergoing Phase 3 trials. Additionally, an open-label extension study has provided valuable insights into the long-term effects and benefits of a specific intervention for COPD patients. Another trial known as Sequence 6 is making significant progress in evaluating new therapeutic approaches for managing COPD symptoms. These studies offer potential breakthroughs that may revolutionize how we understand and treat COPD, offering improved quality of life for individuals affected by this respiratory disorder.

What copd clinical trials were recently completed?

Several recent clinical trials have made significant strides in the field of COPD research. AstraZeneca's trial on Treatment A, BGF MDI HFO with oral activated charcoal, concluded in July 2022. Additionally, Novartis Pharmaceuticals completed the CSJ117 trial in September 2021. In December 2020, Eisai Inc.'s Lemborexant 10 mg study reached completion, while Verona Pharma plc finished two separate Ensifentrine trials in September 2020. Other notable completed trials include Sanofi's Inhaled Long-Acting Beta Agonist study in April 2019 and University of Alabama at Birmingham's Belimumab trial in August 2018. These advancements demonstrate ongoing efforts to enhance treatments for patients grappling with COPD.